Thermo Fisher Scientific (TMO) Restructuring Costs (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Restructuring Costs for 18 consecutive years, with $98.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Restructuring Costs rose 19.51% year-over-year to $98.0 million; the trailing twelve-month figure through Jun 2026 stood at $328.0 million (down 27.59% YoY), and the FY2025 full-year result was $362.0 million, down 4.49% from the prior year.
• Restructuring Costs advanced to $98.0 million in Q2 2026 per TMO's latest filing, from $49.0 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $228.0 million in Q4 2024 and bottomed at $2.0 million in Q2 2022.
• Historically, Restructuring Costs has averaged $81.1 million across 5 years, with a median of $78.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Restructuring Costs slumped 85.71% in 2022, then jumped 5500.0% in 2023.
• Over 5 years, Restructuring Costs stood at $55.0 million in 2022, then soared by 45.45% to $80.0 million in 2023, then soared by 185.0% to $228.0 million in 2024, then sank by 79.82% to $46.0 million in 2025, then surged by 113.04% to $98.0 million in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $98.0 million, $49.0 million, and $46.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.